Key result
Preoperative systolic pulmonary artery pressure ≥40 mmHg was associated with increased 30-day all-cause mortality, with sPAP acting as an independent predictor of mortality.
Why the study?
Pulmonary hypertension is associated with adverse perioperative events, but the specific relationship between preoperative echocardiographic systolic pulmonary artery pressure and perioperative outcomes in non-cardiac surgery required investigation.
Does elevated preoperative systolic pulmonary artery pressure predict perioperative mortality and morbidity in patients undergoing non-cardiac surgery?
Observational (n=3,049)
No
Does elevated preoperative systolic pulmonary artery pressure predict perioperative mortality and morbidity in patients undergoing non-cardiac surgery?
Elevated preoperative systolic pulmonary artery pressure (≥40 mmHg) is an independent predictor of 30-day all-cause mortality and adverse postoperative outcomes in patients undergoing non-cardiac surgery.
Answers are grounded in this paper and cite their sources.
Elevated preoperative sPAP may refine risk stratification before non-cardiac surgery; hypothesis-generating for prospective validation and intervention trials.
OBJECTIVE: Pulmonary hypertension (PH) is associated with adverse perioperative events in patients undergoing non-cardiac surgery. In this study, we aimed to investigate the relationship between systolic pulmonary artery pressure (sPAP), evaluated by transthoracic echocardiography (TTE) before surgery, and perioperative mortality and morbidity in patients who underwent non-cardiac surgery in our center. METHODS: Of the 3425 retrospectively screened patients who underwent non-cardiac surgery, 3049 patients whose estimated sPAP values were previously determined by TTE were included in the study. Patients were classified into 3 groups according to their estimated sPAP levels. sPAP <35 mmHg formed group 1, 35-39 mmHg group 2, and ≥ 40 mmHg group 3. All demographic and perioperative data obtained from the database of our institute were compared in three groups. RESULTS: Of the 3049 patients enrolled in the study, 2406 (78.9%) were in group 1, 259 (8.5%) in group 2, and 384 (12.6%) in group 3. Thirty-day all-cause mortality was observed in 82 (2.7%) patients, cardiac mortality occurred in 9 patients (0.3%). In the group with sPAP ≥40 mmHg, cardiac mortality was 0.5% and all-cause mortality was 7.3%. Thirty-day all-cause mortality, acute pulmonary edema, and acute renal failure were significantly higher in group 3 than in the other groups. Cardiac mortality did not differ significantly between the groups. Age, sPAP value, and chronic obstructive pulmonary disease history were revealed as independent predictors of all-cause mortality in multivariate logistic regression analysis. CONCLUSION: In conclusion, increased sPAP is associated with adverse postoperative outcomes. The evaluation of sPAP with TTE before non-cardiac surgery in patients whose clinical features and examination findings suggest PH may contribute to preoperative risk assessment.
No takes yet. Share an insight, caveat, or question.
A 2023 study conducted an observational in Patients undergoing non-cardiac surgery (n=3,049). Elevated systolic pulmonary artery pressure (sPAP ≥40 mmHg) vs. Normal systolic pulmonary artery pressure (sPAP <35 mmHg) was evaluated on 30-day all-cause mortality (OR 1.037, 95% CI 1.016-1.058, p=0.001). Preoperative systolic pulmonary artery pressure ≥40 mmHg was associated with increased 30-day all-cause mortality, with sPAP acting as an independent predictor of mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: